A pioneering DNA test is being rolled out on the NHS as experts say there is a one in four chance of another pandemic on the scale of Covid-19 in the next decade ...
DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.
Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 companies to do so. The major milestone was a testament to CEO Pascal ...
Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...